Total Funding
7
16
Total FundingGrant raised
Growth Score
-9 pts
Heat Score
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
570729
A spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis.
Sharon McCoy: Vice-President of Product Development and Director of Research
Steven Hefeneider: Founder
About the Company
13Therapeutics, Inc is a spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis. U.S. patents claiming the composition of the lead peptide and its use in all inflammatory conditions involving Toll-Like Receptor (TLR) signaling have been issued, and several additional patents have
been issued. The company performs all in vitro testing in-house and subcontracts with OHSU and other academic instututions for animal model testing. The company is privately funded and has received NIH peer reviewed grants, including multiple Phase II and Phase II SBIR grants.
